Dr. Roger S. McIntyre: Ketamine in Mood Disorders CRTCE
Event Title: Diabetes, Mood Disorders and ADHD; Brain Hazards and Implications for Improving Clinical outcomes Event Date: May 12 2018 Event Location: Mississauga, Ontario Speaker: Roger McIntyre, MD, FRCPC. Professor of Psychiatry and Pharmacology Executive Director, BCDF Head, Mood Disorders Psychopharmacology Unit University of Toronto Topic: Ketamine and Glutamatergic Treatment as Rapid Onset Treatments in Depression; Scientific Rationale and Clinical Application Check out the Canadian Rapid Treatment Center of Excellence https://www.crtce.com/ Talk 4 of 4
▶︎
Dr. Roger McIntyre: Diabetes, Mood Disorders and ADHD
▶︎
Understanding Ketamine Infusion Therapy - Psyched Conference 2022
▶︎
Dr. Tim Guimond- Community reinforcement approach
▶︎
Dr. Roger McIntyre: Managing Depressive Episodes Across the Bipolar Spectrum
▶︎
DR Barometer - Diabetic Retinopathy: Recent advances in treatment and treatment approaches
▶︎
Bipolar Disorder (Roger McIntyre, MD, FRCPC)
▶︎
Ketamine for Unipolar Depression
▶︎
Advances in Stem Cell Therapy
▶︎
Narcolepsy (Sleep Disorder) | Causes, Pathophysiology, Signs & Symptoms, Diagnosis, Treatment
▶︎
Suicide Risk Assessment Reducing Liability and Improving Outcomes
▶︎
The Body Keeps the Score: Dr. Bessel van der Kolk
▶︎
Prof Allan Young - From Cade to Ketamine: the psychopharmacology of mood disorders #BAP2024
▶︎
rTMS & Ketamine Treatment Resistant Depression
▶︎
Dr. Roger McIntyre - Mood Disorders: A Pragmatic Approach to Diagnosis and Management
▶︎
TMS vs. Ketamine: Which One Is Better?
▶︎
Understanding TMS Therapy for Depression and Anxiety | Episode 62 with Jourdan Generes
▶︎
The Science & Treatment of Bipolar Disorder
▶︎
How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎
Bipolar Disorder, Sleep, Chronic Pain | Robert Sapolsky Father-Offspring Interviews #41
▶︎